Outcomes

Male

Female

Total

Survived

32 (86.5%)

6 (37.5%)

38 (71.7%)

Expired

5 (13.5%)

10 (62.5%)

15 (28.3%)

Total

37 (100.0%)

16 (100.0%)

53 (100.0%)